Induction of bona fide regulatory T cells after liver transplantation - The potential influence of polyclonal antithymocyte globulin

Transplant International

Volumn 25, Issue 3, 2012, Pages 302-313

  Stauch, Diana ^a   Yahyazadeh, Ali ^a   Bova, Roberta ^a   Melloh, Götz Christian ^a   Füldner, Arne ^a   Baron, Udo ^b   Olek, Sven ^b   Göldner, Katrin ^a   Weiss, Sascha ^c   Pratschke, Johann ^c   Kotsch, Katja ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b EPIONTIS GMBH   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

liver transplantation; rATG induction therapy; thymoglobulin; Treg

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADULT; ANIMALS; ANTILYMPHOCYTE SERUM; END STAGE LIVER DISEASE; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; METHYLATION; MIDDLE AGED; RABBITS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION CONDITIONING;

EID: 84857036241     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01405.x     Document Type: Article

References (32)

1. Beiras-Fernandez A, Thein E, Hammer C,. Induction of immunosuppression with polyclonal antithymocyte globulins: an overview. Exp Clin Transplant 2003; 1: 79.
2. Lowsky R, Takahashi T, Liu YP, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005; 353: 1321.
3. Oertel M, Sack U, Kohlhaw K, et al. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long term study. Transpl Int 2002; 15: 463.
4. Préville X, Flacher M, LeMauff B, et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 2001; 71: 460.
5. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, Bonnefoy-Berard N,. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 1998; 91: 2360.
6. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N,. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+ CD25+ Foxp3+ regulatory T cells. J Am Soc Nephrol 2006; 17: 2844.
7. Feng X, Kajigaya S, Solomou EE, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+ CD25highFOXP3+ regulatory T cells in vitro. Blood 2008; 111: 3675.
8. Naujokat C, Berges C, Fuchs D, Sadeghi M, Opelz G, Daniel V,. Antithymocyte globulins suppress dendritic cell function by multiple mechanisms. Transplantation 2007; 83: 485.
9. Stauch D, Dernier A, Sarmiento Marchese E, et al. Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity. PLoS ONE 2009; 4: e4709.
10. Ruzek MC, Waire JS, Hopkins D, et al. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood 2008; 111: 1726.
11. Broady R, Yu J, Levings MK,. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. Blood 2009; 114: 5003.
12. Sewgobind VD, Kho MM, van der Laan LJ, et al. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients. Nephrol Dial Transplant 2009; 24: 1635.
13. Gurkan S, Luan Y, Dhillon N, et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant 2010; 10: 2132.
14. Benítez CE, Puig-Pey I, Lõpez M, et al. ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. Am J Transplant 2010; 10: 2296.
15. Baron U, Floess S, Wieczorek G, et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007; 37: 2378.
16. Wing K, Suri-Payer E, Rudin A,. CD4+ CD25+-regulatory T cells from mouse to man. Scand J Immunol 2005; 62: 1.
17. de la Rosa M, Rutz S, Dorninger H, Scheffold A,. Interleukin-2 is essential for CD4+ CD25+ regulatory T cell function. Eur J Immunol 2004; 34: 2480.
18. Olek A, Oswald J, Walter J,. A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 1996; 24: 5064.
19. Wieczorek G, Asemissen A, Model F, et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009; 69: 599.
20. Kohler S, Thiel A,. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood 2009; 113: 769.
21. Morgan ME, van Bilsen JH, Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4+ CD25+ T regulatory cells in humans. Hum Immunol 2005; 66: 13.
22. Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+ CD25- T cells. J Clin Invest 2003; 112: 1437.
23. Pearl JP, Parris J, Hale DA, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005; 5: 465.
24. Kimmig S, Przybylski GK, Schmidt CA, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002; 195: 789.
25. Seddiki N, Santner-Nanan B, Tangye SG, et al. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 2006; 107: 2830.
26. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M,. A peripheral circulating compartment of natural naive CD4 Treg. J Clin Invest 2005; 115: 1953.
27. Akbar AN, Vukmanovic-Stejic M, Taams LS, Macallan DC,. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 2007; 7: 231.
28. Demirkiran A, Sewgobind VD, van der Weijde J, et al. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+ FOXP3+ regulatory T cells. Transplantation 2009; 87: 1062.
29. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY,. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010; 463: 808.
30. Mantel PY, Ouaked N, Rückert B, et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006; 176: 3593.
31. Coenen JJ, Koenen H, Rijssen E, Hilbrands L, Joosten I,. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+ CD25+ regulatory T cells. Blood 2006; 107: 1018.
32. Sewgobind VD, van der Laan LJ, Kho MM, et al. The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins. Clin Exp Immunol 2010; 161: 364.